|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7330 EUR | -2.27% |
|
-5.17% | -52.28% |
| 07-01 | AB Science, successful private placement | |
| 06-30 | AB Science S.A. announced that it has received ?2.294 million in funding | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -33.87 | -44.16 | -34.02 | -15.62 | 1.67 | |||||
Return on Total Capital | 222.19 | 124.1 | 169.13 | 104.48 | -26.35 | |||||
Return On Equity % | 67.67 | 46.26 | 42.29 | 34.99 | 7.6 | |||||
Return on Common Equity | 67.67 | 46.26 | 42.29 | 34.99 | 7.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 93.09 | 96.76 | 60.52 | 116.42 | 83.3 | |||||
SG&A Margin | 253.33 | 367.43 | 364.85 | 316.7 | 206.9 | |||||
EBITDA Margin % | -828.62 | -1.62K | -1.32K | -530.69 | 63.46 | |||||
EBITA Margin % | -832.73 | -1.63K | -1.33K | -546.46 | 57.5 | |||||
EBIT Margin % | -859.24 | -1.66K | -1.38K | -567.44 | 54.43 | |||||
Income From Continuing Operations Margin % | -900 | -1.42K | -1.24K | -730.5 | -132.62 | |||||
Net Income Margin % | -900 | -1.42K | -1.24K | -730.5 | -132.62 | |||||
Net Avail. For Common Margin % | -900 | -1.42K | -1.24K | -730.5 | -132.62 | |||||
Normalized Net Income Margin | -539.36 | -1.05K | -772.23 | -456.56 | -82.89 | |||||
Levered Free Cash Flow Margin | -800.89 | -1.33K | -993.56 | 350.4 | 143.03 | |||||
Unlevered Free Cash Flow Margin | -800 | -1.28K | -895.17 | 415.87 | 210.42 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.06 | 0.04 | 0.04 | 0.04 | 0.05 | |||||
Fixed Assets Turnover | 0.94 | 0.67 | 0.95 | 1.27 | 1.24 | |||||
Receivables Turnover (Average Receivables) | 4.83 | 4.07 | 4.89 | 5.86 | - | |||||
Inventory Turnover (Average Inventory) | 1.01 | 0.1 | 0.97 | -0.68 | 1.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.04 | 0.9 | 1.04 | 0.71 | 0.96 | |||||
Quick Ratio | 0.99 | 0.87 | 0.97 | 0.66 | 0.92 | |||||
Operating Cash Flow to Current Liabilities | -0.98 | -0.76 | -0.9 | 0.03 | -0.29 | |||||
Days Sales Outstanding (Average Receivables) | 75.52 | 89.73 | 74.69 | 62.48 | - | |||||
Days Outstanding Inventory (Average Inventory) | 361.71 | 3.51K | 377.39 | -540.68 | 306.34 | |||||
Average Days Payable Outstanding | 26.01K | 12.46K | 16.18K | -11.77K | 22.47K | |||||
Cash Conversion Cycle (Average Days) | -25.57K | -8.85K | -15.73K | 11.3K | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -64.98 | -77.77 | -90.5 | -77.76 | -113.09 | |||||
Total Debt / Total Capital | -185.58 | -349.81 | -953.13 | -349.63 | 863.68 | |||||
LT Debt/Equity | -62.26 | -64.61 | -80.42 | -61.22 | -108.32 | |||||
Long-Term Debt / Total Capital | -177.82 | -290.61 | -846.97 | -275.28 | 827.22 | |||||
Total Liabilities / Total Assets | 209.06 | 249.62 | 182.4 | 202.5 | 170.12 | |||||
EBIT / Interest Expense | -600.35 | -19.37 | -8.79 | -5.42 | 0.5 | |||||
EBITDA / Interest Expense | -561.83 | -18.39 | -8.15 | -4.82 | 0.71 | |||||
(EBITDA - Capex) / Interest Expense | -586.35 | -19.17 | -8.37 | -4.96 | 0.49 | |||||
Total Debt / EBITDA | -1.17 | -1.83 | -1.53 | -3.41 | 21.68 | |||||
Net Debt / EBITDA | -0.49 | -1.35 | -1.04 | -1.94 | 10.34 | |||||
Total Debt / (EBITDA - Capex) | -1.12 | -1.76 | -1.49 | -3.32 | 31.63 | |||||
Net Debt / (EBITDA - Capex) | -0.47 | -1.3 | -1.01 | -1.88 | 15.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.52 | -40.39 | 1.25 | 10.52 | 9.51 | |||||
Gross Profit, 1 Yr. Growth % | -1.19 | -38.03 | -36.68 | 112.61 | -21.63 | |||||
EBITDA, 1 Yr. Growth % | -7.55 | 16.61 | -17.59 | -55.54 | -113.1 | |||||
EBITA, 1 Yr. Growth % | -7.58 | 16.67 | -17.52 | -54.51 | -111.52 | |||||
EBIT, 1 Yr. Growth % | -6.38 | 15.43 | -15.74 | -54.7 | -110.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -3.87 | -5.86 | -11.97 | -34.66 | -80.12 | |||||
Net Income, 1 Yr. Growth % | -3.87 | -5.86 | -11.97 | -34.66 | -80.12 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.77 | 12.07 | -11.95 | -34.66 | -80.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -10.53 | -4.72 | -16.79 | -37.84 | -80 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.68 | -48.06 | 46.58 | -44.92 | - | |||||
Inventory, 1 Yr. Growth % | 78.48 | 223.4 | -26.32 | -45.24 | -21.2 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -12.66 | -20.51 | -38.04 | 14.52 | 10.79 | |||||
Total Assets, 1 Yr. Growth % | -28.35 | 12.08 | 6.95 | -9.11 | 5.83 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.13 | 51.48 | -39.91 | 11.9 | -25.18 | |||||
Common Equity, 1 Yr. Growth % | 18.67 | 53.76 | -41.1 | 13.06 | -27.6 | |||||
Cash From Operations, 1 Yr. Growth % | 27.14 | 1.71 | -3.43 | -103.11 | -916.95 | |||||
Capital Expenditures, 1 Yr. Growth % | 52.43 | 14.18 | -46.43 | -55.07 | 81.94 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 73.17 | -0.66 | -24.62 | -138.98 | -55.3 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 74.69 | -4.55 | -29.24 | -151.34 | -44.59 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.14 | -22.21 | -22.31 | 5.78 | 10.01 | |||||
Gross Profit, 2 Yr. CAGR % | 3.74 | -21.75 | -37.36 | 16.03 | 29.08 | |||||
EBITDA, 2 Yr. CAGR % | -11.42 | 3.83 | -1.97 | -39.47 | -75.87 | |||||
EBITA, 2 Yr. CAGR % | -11.39 | 3.84 | -1.9 | -38.75 | -77.1 | |||||
EBIT, 2 Yr. CAGR % | -11.11 | 3.95 | -1.38 | -38.22 | -78.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -18.45 | -4.87 | -8.97 | -24.16 | -63.96 | |||||
Net Income, 2 Yr. CAGR % | -18.45 | -4.87 | -8.97 | -24.16 | -63.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | -20.14 | 3.69 | -8.86 | -24.15 | -63.96 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -25.74 | -7.67 | -10.96 | -28.08 | -64.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | 25.44 | -32.66 | -12.75 | -10.14 | - | |||||
Inventory, 2 Yr. CAGR % | -21.7 | 140.25 | 54.37 | -36.48 | -34.31 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -14.33 | -16.68 | -29.82 | -15.77 | 12.64 | |||||
Total Assets, 2 Yr. CAGR % | 9.5 | -10.39 | 9.49 | -1.41 | -1.93 | |||||
Tangible Book Value, 2 Yr. CAGR % | -6.64 | 33.2 | -4.59 | -18 | -8.5 | |||||
Common Equity, 2 Yr. CAGR % | -7.01 | 35.08 | -4.83 | -18.4 | -9.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.46 | 13.71 | -0.9 | -82.67 | -49.58 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.26 | 31.93 | -21.79 | -50.94 | -9.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 15.85 | 31.16 | -13.47 | -45.8 | -58.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 15.85 | 29.13 | -17.82 | -39.73 | -46.66 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.88 | -15.2 | -15.06 | -12.62 | 7.01 | |||||
Gross Profit, 3 Yr. CAGR % | 0.98 | -12.63 | -27.08 | -5.86 | 1.8 | |||||
EBITDA, 3 Yr. CAGR % | -22.2 | -2.91 | -3.86 | -24.68 | -63.66 | |||||
EBITA, 3 Yr. CAGR % | -22.15 | -2.88 | -3.84 | -24.07 | -64.9 | |||||
EBIT, 3 Yr. CAGR % | -21.86 | -3.02 | -3.08 | -23.91 | -65.77 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -17.82 | -14.45 | -7.3 | -18.49 | -51.46 | |||||
Net Income, 3 Yr. CAGR % | -17.82 | -14.45 | -7.3 | -18.49 | -51.46 | |||||
Normalized Net Income, 3 Yr. CAGR % | -18.96 | -9.4 | -7.28 | -18.43 | -51.46 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -23.88 | -19.31 | -10.82 | -21.01 | -53.06 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.52 | -6.51 | -12.72 | -25.15 | - | |||||
Inventory, 3 Yr. CAGR % | -2.69 | 25.63 | 62.02 | 9.28 | -31.74 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 118.41 | -16.45 | -24.51 | -17.38 | -7.71 | |||||
Total Assets, 3 Yr. CAGR % | -1.84 | 10.35 | -4.94 | 2.9 | 0.95 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.19 | 9.71 | 2.16 | 0.62 | -20.46 | |||||
Common Equity, 3 Yr. CAGR % | 15.74 | 9.96 | 2.43 | 0.79 | -21.59 | |||||
Cash From Operations, 3 Yr. CAGR % | -13.77 | 4.85 | 7.68 | -68.73 | -37.38 | |||||
Capital Expenditures, 3 Yr. CAGR % | 5.23 | 18.2 | -2.3 | -34.98 | -24.06 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -8.08 | 10.07 | 9.05 | -33.67 | -49.17 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -8.12 | 8.61 | 5.67 | -29.74 | -41.39 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.28 | -11.24 | -10.63 | -7.36 | -5.8 | |||||
Gross Profit, 5 Yr. CAGR % | 7.23 | -10.54 | -16.58 | -2.13 | -8.37 | |||||
EBITDA, 5 Yr. CAGR % | -14.76 | -11.1 | -14.66 | -19.63 | -44.7 | |||||
EBITA, 5 Yr. CAGR % | -14.73 | -11.06 | -14.61 | -19.23 | -45.84 | |||||
EBIT, 5 Yr. CAGR % | -14.49 | -10.91 | -14.24 | -19.03 | -46.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -12.19 | -12.88 | -14.39 | -18.48 | -36.47 | |||||
Net Income, 5 Yr. CAGR % | -12.19 | -12.88 | -14.39 | -18.48 | -36.47 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.93 | -9.82 | -14.39 | -18.47 | -36.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -17.09 | -17.39 | -18.95 | -22.94 | -38.47 | |||||
Accounts Receivable, 5 Yr. CAGR % | -15.77 | -24.61 | 0 | -7.98 | - | |||||
Inventory, 5 Yr. CAGR % | 1.02 | 23.46 | 17.04 | -4.36 | 12.91 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 49.42 | 49.26 | 38.69 | -16.17 | -11.41 | |||||
Total Assets, 5 Yr. CAGR % | -10.96 | -13.97 | 2.54 | 5.49 | -3.75 | |||||
Tangible Book Value, 5 Yr. CAGR % | 31.19 | 32.9 | 6.27 | -2.35 | -2.24 | |||||
Common Equity, 5 Yr. CAGR % | 37.59 | 27.15 | 7.03 | -2.41 | -2.53 | |||||
Cash From Operations, 5 Yr. CAGR % | -12.52 | -5.26 | -8.84 | -48.96 | -20.51 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.48 | 5.07 | -6.55 | -16.85 | -5.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -11.24 | -0.07 | -10.28 | -17.09 | -25.73 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -11.04 | -0.89 | -12.13 | -14.18 | -19.61 |
- Stock Market
- Stocks
- AB Stock
- Financials AB Science
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















